HK1103278A1 - Use of timosaponin bii for treating stroke - Google Patents

Use of timosaponin bii for treating stroke

Info

Publication number
HK1103278A1
HK1103278A1 HK07107274.5A HK07107274A HK1103278A1 HK 1103278 A1 HK1103278 A1 HK 1103278A1 HK 07107274 A HK07107274 A HK 07107274A HK 1103278 A1 HK1103278 A1 HK 1103278A1
Authority
HK
Hong Kong
Prior art keywords
timosaponin bii
treating stroke
improve
stroke
timosaponin
Prior art date
Application number
HK07107274.5A
Other languages
English (en)
Inventor
Baiping Ma
Qiuping Xu
Yang Zhao
Chengqi Xiong
Dawei Tan
Original Assignee
Inst Radiation Med Amms Pla
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Radiation Med Amms Pla filed Critical Inst Radiation Med Amms Pla
Publication of HK1103278A1 publication Critical patent/HK1103278A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK07107274.5A 2004-04-29 2007-07-06 Use of timosaponin bii for treating stroke HK1103278A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN200410037347 2004-04-29
CN200510059466XA CN1692914B (zh) 2004-04-29 2005-03-25 知母皂苷bⅱ在制备用于防治脑卒中药物或产品中的用途
PCT/CN2005/000553 WO2005105108A1 (fr) 2004-04-29 2005-04-21 Utilisation de timosaponine bii dans la preparation de medicaments ou de produits servant a prevenir et a traiter l'accident vasculaire cerebral

Publications (1)

Publication Number Publication Date
HK1103278A1 true HK1103278A1 (en) 2007-12-14

Family

ID=35241426

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07107274.5A HK1103278A1 (en) 2004-04-29 2007-07-06 Use of timosaponin bii for treating stroke

Country Status (11)

Country Link
US (1) US7998936B2 (zh)
EP (1) EP1741434B1 (zh)
JP (1) JP4987695B2 (zh)
KR (1) KR101118112B1 (zh)
CN (1) CN1692914B (zh)
AT (1) ATE517627T1 (zh)
CA (1) CA2564887C (zh)
HK (1) HK1103278A1 (zh)
PL (1) PL381613A1 (zh)
RU (1) RU2376993C2 (zh)
WO (1) WO2005105108A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8796248B2 (en) 2007-10-05 2014-08-05 Nektar Therapeutics Oligomer-corticosteroid conjugates
EP2291192A2 (en) * 2008-04-11 2011-03-09 Bionovo Inc. Anticancer methods using extracts of anemerrhena asphodeloides bungle
EP2389182A1 (en) 2009-01-24 2011-11-30 Phytopharm PLC Treatment of neurotrophic factor mediated disorders
US20120316122A1 (en) * 2009-09-07 2012-12-13 Institute Of Radiation Medicine, Academy Of Military Medical Sciences ,Pla Pharmaceutical compositions for combating thrombotic diseases and their preparation and uses
CN110540603B (zh) * 2019-08-30 2021-12-24 南开大学 知母多糖及其制备方法、鉴定方法和应用
CN111249294B (zh) * 2020-03-17 2021-01-15 皖南医学院 一种知母皂苷bii、aiii、ai或biii在制备抗肺纤维化药物方面的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5632418A (en) * 1979-08-28 1981-04-01 Sunstar Inc Antithrombic agent containing crude drug
CN1033754C (zh) * 1993-05-31 1997-01-08 上海第二医科大学 知母皂甙元作为制备β肾上腺素和M胆碱受体双向调节药的用途及其制法
CN1131237C (zh) * 1997-09-26 2003-12-17 中国人民解放军军事医学科学院放射医学研究所 甾体皂甙防治老年性痴呆的用途及新的甾体皂甙
JP2000204043A (ja) * 1999-01-13 2000-07-25 Otsuka Pharmaceut Factory Inc 活性酸素生成阻害剤および抗炎症剤
CN1199643C (zh) * 2003-05-09 2005-05-04 中国人民解放军第二军医大学 知母总皂苷用于制备防治脑卒中药物的用途

Also Published As

Publication number Publication date
US7998936B2 (en) 2011-08-16
EP1741434A4 (en) 2008-05-21
CN1692908A (zh) 2005-11-09
US20090075912A1 (en) 2009-03-19
CA2564887C (en) 2012-07-24
PL381613A1 (pl) 2007-06-11
RU2376993C2 (ru) 2009-12-27
RU2006142098A (ru) 2008-06-20
JP2007534705A (ja) 2007-11-29
CN1692914B (zh) 2010-05-26
EP1741434B1 (en) 2011-07-27
KR101118112B1 (ko) 2012-03-13
KR20070037573A (ko) 2007-04-05
ATE517627T1 (de) 2011-08-15
CA2564887A1 (en) 2005-11-10
EP1741434A1 (en) 2007-01-10
JP4987695B2 (ja) 2012-07-25
WO2005105108A1 (fr) 2005-11-10

Similar Documents

Publication Publication Date Title
HK1103278A1 (en) Use of timosaponin bii for treating stroke
EP2173344A4 (en) TREATMENT OR PROPHYLAXIS OF NEUROLOGICAL OR NEUROPSYCHIATRIC DISORDERS BY OCULAR ADMINISTRATION
WO2018151861A8 (en) Methods of treating schizophrenia
MX2019012818A (es) Metodos para mejorar la memoria y la cognicion y para el tratamiento de trastornos de la memoria y cognitivos.
WO2007137167A3 (en) Co-therapy for the treatment of epilepsy
WO2008131298A3 (en) Prevention and treatment of cerebral amyloid angiopathy
DE602006020353D1 (de) Progesterone Dosierungsanweisung in der Behandlung einer traumatischen Verletzung des Gehirns
IL191311A (en) Transdermal therapeutic system and its use in the preparation of drugs for the prevention, treatment or delay of the progression of Alzheimer's disease, Parkinson's disease-related dementia and symptoms of traumatic brain injury
WO2007103549A3 (en) Complement binding aptamers and anti-c5 agents useful in the treatment of ocular disorders
AR065033A1 (es) Metodos para prevenir y tratar trastornos neurodegenerativos
WO2019209962A8 (en) Compounds and uses thereof
WO2004096216A3 (en) Use of a topical medicament comprising riluzole
WO2009143380A3 (en) Methods for treating progressive cognitive disorders related to neurofibrillary tangles
WO2008006070A3 (en) Compounds and combinations thereof for inhibiting beta-amyloid production and methods of use thereof
MX2021011488A (es) Compuestos y usos de estos.
EA201991650A1 (ru) Способы лечения неврологических расстройств
MX2024000349A (es) Compuestos y usos de los mismos.
PL1704860T3 (pl) Pochodne benzamidyny do leczenia i zapobiegania zapaleniu śluzówki
WO2019209948A8 (en) Compounds and uses thereof
WO2008001369A8 (en) Use of cb2 receptor agonists for promoting neurogenesis
MX2024006769A (es) Compuestos y usos de los mismos.
WO2008090209A3 (en) Use of glucopyranosyloxy- pyrazoles for preventing and treating neurodegenerative disorders
EP1865954A4 (en) METHOD FOR AVOIDING OEDEM IN THE TREATMENT OR PREVENTION OF DISEASES AFFECTING PPAR GAMMA INCLUDING CANCER
BRPI0608328A2 (pt) uso de lactobacillus rhamnosus gg para tratamento, prevenção ou redução de inflamação sistêmica em um bebê alimentado com fórmula
WO2015061777A3 (en) Therapy for chronic idiopathic urticaria, anaphylaxis and angioedema